Method and system for measuring degree of muscle displacement and use of method and system in treatment of obstructive sleep apnea

By using electrodes and motion sensing units to detect airway muscle movement in obstructive sleep apnea patients, the problem of quantitatively evaluating the therapeutic effect of nerve modulation in the prior art is solved, and the accurate monitoring of the therapeutic effect of obstructive sleep apnea is achieved. and adjust.

CN118984676APending Publication Date: 2024-11-19NYXOAH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380026804.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-11
Filing Date
2023-03-03
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The prior art is difficult to accurately quantify the efficacy of neuromodulation therapy on obstructive sleep apnea, especially since airflow monitoring is not suitable for seamless implementation and self-evaluation methods subjective and qualitative, and lacks quantitative results.

Method used

Movement of the subject's airway-related muscles is detected by generating modulation signals and applying them to the electrodes associated with the implant unit, determining the degree of muscle displacement to evaluate airway opening and obstruction, using motion sensing units such as inertial measurement units and strain gauges Monitor chin movements and adjust electrical stimulation parameters to achieve closed-loop stimulation.

Benefits of technology

Accurate monitoring of neurostimulation therapy is achieved, quantitative measurement of muscle displacement is provided, and treatment parameters can be continuously monitored and adjusted to improve treatment effect, providing effective treatment for obstructive sleep apnea.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118984676A_ABST
    Figure CN118984676A_ABST
Patent Text Reader

Abstract

The invention described herein relates to a method for measuring the degree of airway opening, such as the degree of muscle displacement, to a system for implementing the method, and to the use of the method and system in the treatment of obstructive sleep apnea.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention described herein relates to a method for measuring the degree of muscle displacement, a system for implementing the method, and the use of the method and system in the treatment of obstructive sleep apnea. Background Art

[0002] Neural modulation (i.e., electrical stimulation of nerves) is well known in the art as a reliable and effective type of medical treatment. It provides the opportunity to treat many physiological conditions and disorders by interacting with the body's own natural neural processes. Neural modulation includes inhibition (e.g., blocking), stimulation, alteration, modulation, or therapeutic change of electrical or chemical activity in the central, peripheral, or autonomic nervous system. By modulating the activity of the nervous system, several different goals can be achieved. For example, motor neurons can be stimulated at the appropriate time to cause muscle contraction. In addition, sensory neurons can be blocked to relieve pain or stimulated to provide signals to the subject. In other examples, modulation of the autonomic nervous system can be used to adjust various non-autonomous physiological parameters, such as heart rate and blood pressure. Neural modulation can provide the opportunity to treat several diseases or physiological conditions. Various devices and techniques have been used to try to provide optimal stimulation to the tissue of interest.

[0003] Within the content of the present disclosure, the expressions "neurostimulation", "stimulation of a nerve", "neuromodulation" and "modulation of a nerve" are used synonymously, unless otherwise apparent from the corresponding context. Generally, the above expressions refer to the process of generating an electric field near a nerve or a group of nerves to induce contraction of one or more muscles associated with the nerves. Likewise, the expressions "subject" and "patient" are used synonymously, unless otherwise apparent from the corresponding context. Both terms refer to a person who may suffer from OSA.

[0004] One of the conditions to which neuromodulation may be applied is obstructive sleep apnea (OSA), a breathing disorder characterized by recurrent episodes of partial or complete obstruction of the upper airway during sleep. One of the main causes of OSA is that the tongue muscles are unable to resist the negative inspiratory pressure in the pharynx due to a sleep-related loss of muscle tone. When the tongue is pulled back, it obstructs the upper airway, reducing ventilation and lowering lung and blood oxygen levels. Stimulation of the hypoglossal nerve ("hypoglossal nerve stimulation" or HGNS) causes the tongue muscles to contract, thereby maintaining an open, unobstructed airway. When a person without OSA sleeps, the pharyngeal muscles (the group of muscles that form the pharynx) relax and gradually collapse, narrowing the airway. The narrowed airway in turn limits the effectiveness of the sleeper's breathing, resulting in increased CO2 levels in the sleeper's blood. The increase in CO2 causes the pharyngeal muscles to contract to open the airway to restore proper breathing. The largest of the pharyngeal muscles responsible for upper airway dilation is the genioglossus muscle, which is one of several different muscles in the tongue.

[0005] The genioglossus muscle is responsible for the forward movement of the tongue as well as stiffening of the anterior pharyngeal wall. In patients with OSA, the neuromuscular activity of the genioglossus muscle is reduced compared to normal individuals, which indicates that the response and contraction to open the airway are insufficient compared to normal individuals. This lack of response leads to partial or complete airway obstruction, which significantly limits the effectiveness of the sleeper's breathing. In patients with OSA, there are usually several airway obstruction events during the night. Due to the obstruction, the O2 level in the blood gradually decreases (hypoxemia). Hypoxemia leads to nocturnal arousals, which can be recorded by EEG, indicating that the brain wakes up from any stage of sleep to a brief awakening. During the arousal, there is conscious breathing or gasping, which resolves the airway obstruction. Increased sympathetic tone activity rate through the release of hormones (e.g., epinephrine and norepinephrine) also often occurs as a response to hypoxemia. Due to the increase in sympathetic tone, the heart enlarges in an attempt to pump more blood and increases blood pressure and heart rate, further arousing the patient after the apneic event subsides, and when the patient returns to sleep, the airway collapses again, causing more arousals.

[0006] In order to quantify the efficacy of neuromodulation as a treatment approach (particularly for HGN) and for analytical purposes, it is important to closely monitor the treatment response. This is typically accomplished by monitoring the subject's nasal and / or oral airflow, such as in the case of the use of a PSG (sleep study or polysomnography) or a CPAP (continuous positive airway pressure) mask. Alternatively, the patient can self-assess the efficacy of the treatment during awake titration. Other methods may include visual observation of airway opening or tongue protrusion to assess whether the treatment results in the desired motor response. Further assessments of treatment response include drug-induced or awake endoscopy.

[0007] The above methods have several disadvantages. Solutions involving airflow are not suitable for seamless implementation in existing systems for neurostimulation. Furthermore, the use of masks and the like may be perceived as annoying by the subject. As for self-assessment or visualization of airway patency or tongue protrusion, these methods may be highly subjective and therefore subject to variable results or errors. Furthermore, even objective visual assessments only provide qualitative results rather than quantitative results.

[0008] The objective technical problem of the present disclosure is to eliminate the disadvantages of the prior art and provide a method for measuring the degree of airway patency (e.g. the degree of muscle displacement) in order to quantify the efficacy of neuromodulation therapy. In addition, the method should improve electrical nerve stimulation for patients associated with OSA. Summary of the invention

[0009] The main features of the method according to the present disclosure are specified by claim 1. Specific embodiments or advantageous variants of the method are described in claims 2 to 7. Claims 8 to 9 specify a system for implementing the method. Furthermore, claim 10 specifies the use of the method.

[0010] According to a first aspect of the present disclosure, the objective technical problem is solved by a method for measuring the degree of muscle collapse and / or contraction of a subject in response to electrical nerve stimulation, the method comprising:

[0011] - generating a modulation signal, the modulation signal comprising an electrical stimulation pattern;

[0012] - applying a modulated signal to at least one pair of electrodes associated with an implant unit implanted in a subject;

[0013] - detecting movement of one or more muscles associated with the airway of the subject in response to the modulated signal applied to the at least one pair of electrodes;

[0014] - Assigning to the determined movement a value indicative of the degree of airway openness and / or obstruction (eg the degree of muscle displacement).

[0015] Utilizing the method as described above, the efficacy of neurostimulation, in particular the efficacy of stimulation of the hypoglossal nerve or ansa cervicalis, during treatment of a patient with OSA can be monitored in a simple and accurate manner. It will be appreciated that the hypoglossal nerve innervates the genioglossus muscle, and the ansa cervicalis innervates the infrahyoid strap muscles, which are responsible for stiffening or collapsing the subject's upper airway. The infrahyoid muscles include the sternohyoid, sternothyroid, omohyoid, and thyrohyoid muscles. In addition, if desired, the system allows for continuous monitoring over a desired period of time, thereby providing important information regarding the long-term effects of the neurostimulation therapy.

[0016] In the sense of the present disclosure, muscle contraction may refer to muscle displacement, and unless otherwise specified, these expressions are used synonymously. Muscle contraction may particularly refer to (but not limited to) displacement of the subject's tongue or other muscles associated with the subject's airway.

[0017] In the sense of the present disclosure, movement of one or more muscles associated with the subject's airway may also include movement of the subject's jaw, since contraction of one or more muscles involved in tongue movement will also cause the jaw to move. Thus, the degree of airway patency and / or airway obstruction, such as the degree of muscle displacement, may also be determined by measuring the subject's jaw movement.

[0018] The modulated signal comprising the electrical stimulation pattern is preferably generated by an external device that can be configured to be placed under the chin of the subject. In particular, the modulated signal can be generated by a control unit and / or a processor, both of which can be part of the external unit. The modulated signal can also be transmitted to the implanted unit using a transmitting element, which can include an antenna or a coil associated with the control unit.

[0019] According to another embodiment, instead of a control unit of an external device or a control unit attached to an external device, the control unit can be part of an implanted unit implanted under the skin of the subject. In this way, the control unit can be located directly on the muscle to be monitored, for example, on the genioglossus muscle or on one or more of the infrahyoid muscles, in particular on the sternohyoid muscle or the sternothyroid muscle. In other words, the location of the control unit is not essential for the basic method of the present disclosure. In either case, the control unit can preferably be in electrical communication with at least one motion sensing unit.

[0020] The step of applying the modulated signal to at least one pair of electrodes may preferably be accomplished by an implant unit. The implant unit may be implantable around or near any muscle associated with the airway of the subject (e.g., the genioglossus muscle), which is innervated by the hypoglossal nerve. The implant unit may include circuitry that receives the electrical stimulation pattern via electrical communication between an external device and the implant unit, and in turn generates an electric field via at least one pair of electrodes associated with the implant unit.

[0021] The step of determining the movement of one or more muscles associated with the subject's airway opening in response to the modulated signal can preferably be implemented by a motion sensing unit. Likewise, muscles associated with the subject's airway opening are also the cause of airway obstruction, which can be detected using the method described herein. The method can also be characterized in that at least one motion sensing unit includes at least one inertial measurement unit (IMU) and / or at least one strain gauge. According to an exemplary embodiment, the movement of one or more muscles associated with the subject's airway opening and / or airway obstruction can also be determined by detecting the movement of the subject's jaw, because the movement of muscles associated with the subject's airway opening and / or airway obstruction (particularly the movement of the subject's tongue) will also cause the movement of the subject's jaw.

[0022] Using the proposed method, the actual physiological effect achieved by the stimulation therapy, i.e., the contraction (or non-contraction) of the target muscle or muscle group, can be monitored, rather than the symptoms of the disease or disorder. Since the latter may not be immediately improved by the treatment in some cases, they can be misleading when monitored and used as a basis for adjusting the stimulation. For example, if the patient or subject suffers from a disorder such as central sleep apnea (CSA), measurements of airflow in response to neurostimulation therapy will indicate apneic events. This would indicate the ineffectiveness of the treatment and potentially lead to a decision to increase the intensity of the stimulation. However, since the stimulation therapy will not prevent apneic events in CSA in the first place, increasing or decreasing the stimulation intensity (or adjusting any other stimulation parameter) will not affect the patient's condition with respect to the sleep apnea disorder. Therefore, airflow is not a viable indicator for determining the efficacy of neurostimulation.

[0023] Using the methods described herein, physiological conditions that are directly affected by potential neural stimulation treatments, namely muscle contractions, are monitored. In this way, accurate information about the efficacy of the treatment can be obtained. Based on the determined degree of muscle displacement in response to stimulation with a defined set of stimulation parameters, those parameters can also be adjusted to improve the efficacy of the treatment. For example, if a set of stimulation parameters is not sufficient to cause tongue protrusion and open the airway, the potential stimulation parameters can be adjusted accordingly, such as by increasing the stimulation intensity.

[0024] According to another embodiment of the method, a threshold degree of airway openness and / or airway obstruction (e.g., muscle displacement) may be predefined. In this case, a value indicative of airway openness will only be assigned to the determined muscle movement if the threshold degree of airway openness is exceeded. Airway openness may, for example, include tongue protrusion caused by innervation of the genioglossus muscle, or widening of the upper airway caused by innervation of one or more hypoglossal muscles.

[0025] According to one embodiment disclosed herein, the method further comprises the following steps: adjusting at least one parameter of the electrical stimulation pattern in response to a value indicating the degree of airway patency (e.g., muscle displacement). In this way, a stimulation method based on feedback or closed loop is provided, in which the efficacy of an ongoing stimulation session is determined by measuring the degree of displacement of the subject's muscles in response to the associated neural stimulation, and then adjusting the stimulation parameters in response to the measured degree of airway patency and / or airway obstruction. The degree of airway patency and / or airway obstruction can be determined, for example, by detecting the movement of muscles associated with the tongue (i.e., collapse or protrusion) or by detecting the movement of the subject's jaw. The adjustment of at least one stimulation parameter can occur automatically or manually (e.g., by a physician or by the subject himself) or both. In the case of automatic adjustment, at least one stimulation parameter can be changed after a set time delay or more or less immediately (i.e., in real time). The process can be automatically repeated in an iterative manner until one of the automatic adjustments of the stimulation parameters results in determining a value indicating a muscle contraction associated with the desired degree of airway patency and / or airway obstruction.

[0026] To implement a feedback-based stimulation session or a closed-loop stimulation session, the control unit can be configured to perform logical operations, such as comparing the detected degree of movement (or inactivity) of one of the muscles associated with the subject's airway to a predetermined value and adjusting one or more stimulation parameters accordingly. For example, in the event that the detected degree of tongue displacement or jaw movement is below a predetermined value, the control unit can be configured to increase the intensity of the stimulation. As another example, in the event that the degree of tongue collapse is above a predetermined value (i.e., resulting in airway obstruction in the subject), the control unit can be configured to induce stimulation.

[0027] Advantageously, movement of muscles associated with the subject's airway may include muscle contraction, change in tongue position and / or change in the spatial orientation of the tongue within the subject, and / or movement of the subject's jaw. In particular, but not exclusively, muscle contraction may refer to contraction of the genioglossus muscle, particularly when innervated by the hypoglossal nerve.

[0028] It is also possible to use at least one motion sensing unit to determine the movement of one or more muscles associated with the subject's tongue. The method may also be characterized in that the at least one motion sensing unit includes at least one inertial measurement unit and / or at least one strain gauge. According to another embodiment, the inertial measurement unit may include at least one accelerometer and / or at least one gyroscope and / or at least one magnetometer. Preferably, at least one accelerometer may be implemented, wherein the accelerometer may include a single-axis accelerometer or a multi-axis accelerometer.

[0029] At least one parameter may include pulse train amplitude, pulse train length, single pulse frequency, single pulse duration, hold duration, pulse train interval, duty cycle, delay time, ramp duration, step-down amplitude, ramp at train start duration, and / or confirmed pulse / train amplitude. The stimulation parameters may be adjusted automatically based on the values ​​assigned to the measured degree of airway patency and / or airway obstruction, or the parameters may be adjusted by the physician or the patient themselves upon receiving information that the current stimulation parameters are insufficient.

[0030] According to another aspect of the present invention, a system for measuring the degree of airway patency and / or airway obstruction (e.g., muscle displacement) of a subject is provided, the system comprising:

[0031] - an implant unit configured for implantation around or near any muscle associated with the airway of the subject, such as one of the infrahyoid strap muscles or the genioglossus muscle, the implant unit comprising at least one pair of electrodes;

[0032] - an external device configured to communicate with the implanted unit;

[0033] - at least one motion sensing unit for determining movement of one or more muscles associated with the airway of the subject in response to a modulated signal applied to the at least one pair of electrodes.

[0034] The system may preferably be configured to implement the methods described herein.

[0035] In addition to the above, the system may include a control unit. The control unit may be part of an external device. In this case, the control unit may transmit a modulation or stimulation input signal (e.g., a stimulation parameter) and power to the implanted unit. The control unit may also receive determined data corresponding to the movement of one or more muscles associated with the subject's tongue as determined by the motion sensing unit, and assign a value to the degree of airway patency and / or airway obstruction. According to a preferred embodiment, the control unit is also capable of modulating at least one of the stimulation parameters in response to a value indicating the degree of airway patency and / or airway obstruction (e.g., muscle displacement).

[0036] Thus, the control unit may include one or more processors, which may include any circuit configured to perform a logical operation on at least one input variable. Thus, at least one processor of the control unit may include one or more integrated circuits, microchips, microcontrollers and microprocessors, which may be all or part of a central processing unit (CPU), a digital signal processor (DSP), a field programmable gate array (FPGA) or any other circuit known to those skilled in the art that may be suitable for executing instructions or performing logical operations.

[0037] The implant unit can be configured for implantation in a location that allows it to modulate a nerve (e.g., the hypoglossal nerve). The implant unit can be located within the subject such that there is intervening tissue between the implant unit and the nerve to be modulated. The intervening tissue can include muscle tissue, connective tissue, organ tissue, or any other type of biological tissue. Thus, the location of the implant unit does not need to be in immediate contact with the nerve for effective neuromodulation. The implant unit can also be positioned directly adjacent to the nerve such that there is no intervening tissue.

[0038] In treating OSA, the implant unit may be located on the genioglossus muscle of the patient or subject. Such a location is suitable for modulation of the hypoglossal nerve, wherein branches of the hypoglossal nerve run inside the genioglossus muscle and innervate the genioglossus muscle. However, the implant unit may also be configured to be placed in other locations.

[0039] The external device can be configured to be positioned externally to the patient, in direct contact with the skin or near the patient's skin. The external device can also be configured to be secured to the patient, such as by adhering to the patient's skin or by a band or other device configured to hold the external device in place. Adherence of the external unit to the skin can occur so that it is around or near the location of the implanted unit.

[0040] The external device may be configured to be fixed to the patient. For example, the external device may be configured to be placed under the subject's chin and / or the front of the patient's neck. The suitability of the placement position may be determined by communication between the external device and the implant unit. The external device may include a housing, wherein the housing may be any suitable container configured to hold electrical components. In addition, the housing may be of any suitable size and / or shape, and may be rigid or flexible. Examples of housings for external devices may include one or more of patches, buttons, or other containers having different shapes and sizes and made of any suitable material. The external device may be configured to adhere to a desired position. Therefore, in some embodiments, at least one side of the housing may include an adhesive material. The adhesive material may include a biocompatible material, and may allow the patient to adhere the external unit to a desired position and remove the external device when use is complete. The adhesive may be configured for single or multiple uses of the external unit. Suitable adhesive materials may include, but are not limited to, biocompatible glues, starches, elastomers, thermoplastics, and emulsions.

[0041] According to one embodiment, the at least one motion sensing unit may be part of the implanted unit and / or the at least one motion sensing unit may be part of the external device. Both the implanted unit and the external device may also comprise a motion sensing unit. If this is the case, the motion sensing units may be different from each other, i.e. the motion sensing unit of the internal unit may be a strain gauge and the motion sensing unit of the external device may be an accelerometer. For example, if the motion sensing unit is part of the external device, the motion sensing unit may preferably be an IMU configured to detect jaw movement, because the external device is preferably located under the chin of the subject and because a stimulation event that causes contraction of one or more muscles associated with tongue movement will also cause movement of the subject's jaw.

[0042] If the motion sensing unit is part of the implanted unit, the motion sensing unit may preferably comprise strain gauges, either as a separate component or together with the IMU, since strain gauges are suitable for detecting and measuring muscle contractions.

[0043] According to another aspect of the present disclosure, the use of the method disclosed herein for treating obstructive sleep apnea is proposed. The treatment of obstructive sleep apnea that can use this method can, for example, include the following steps:

[0044] - receiving a modulated signal at an implant unit implanted at an internal location on the underside of the subject's chin (e.g., near the genioglossus muscle);

[0045] - applying the modulated signal to at least one pair of electrodes associated with the implant unit to generate an electric field;

[0046] - and causing modulation of the subject's hypoglossal nerve or cervical loop in response to an electric field generated by at least one pair of electrodes, wherein modulation of the hypoglossal nerve may be confined to a medial branch of the hypoglossal nerve and may begin at a single modulation site along the medial branch.

[0047] Thus, at least one pair of modulating electrodes can be configured for implantation through the dermis on the underside of the subject's chin and for proximity to the location of the terminal fibers of the medial branch of the subject's hypoglossal nerve. Additionally, the implantable unit and the electrodes can be configured to cooperate to generate an electric field suitable for modulating one or more of the terminal fibers of the medial branch of the hypoglossal nerve.

[0048] Any of the embodiments, examples, or features disclosed herein may be used in combination or alone and in conjunction with any aspect of the disclosed subject matter. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate several examples of the disclosed subject matter. The accompanying drawings show the following:

[0050] FIG1 shows a schematic diagram of a system disclosed herein according to a first embodiment;

[0051] FIG2 shows a schematic diagram of a system according to a second embodiment;

[0052] FIG3 shows a schematic diagram of a system according to a third embodiment. DETAILED DESCRIPTION

[0053] FIG1 shows a schematic diagram of a system 100 for measuring the degree of airway openness and / or airway obstruction (e.g., muscle displacement) of a subject in response to electrical neural stimulation, wherein the muscle is part of a muscle group responsible for the subject's breathing, such as the tongue, the genioglossus, or one or more infrahyoid strap muscles. The flowchart of FIG1 can be used as a representation of the basic concept of the method. According to FIG1 , a neural stimulation system 100 configured to implement the method includes a control unit 500 and a motion sensing unit 400. In addition, the system 100 may preferably include an implant unit 200 (not shown) and an external device 300 (not shown), the implant unit 200 being configured to be implanted near any muscle associated with the subject's airway (e.g., the genioglossus), and the external device 300 being configured to electrically communicate with the implant unit 200.

[0054] The implant unit 200 of the system 100 that can be used to perform the method can be implanted near the genioglossus muscle innervated by the hypoglossal nerve, or implanted near one of the infrahyoid muscles innervated by the cervical loop. The implant unit 200 can also include a transmitting element and a circuit, the transmitting element can include a secondary antenna or coil, and the circuit receives the electrical stimulation pattern through electrical communication between the external device 300 and the implant unit 200. Upon receiving the electrical stimulation pattern, the circuit can generate an electric field via at least one pair of electrodes associated with the implant unit 200. If the electric field is strong enough and / or close enough to the nerve, the nerve will be stimulated and innervate the associated muscle, which in turn will contract. The specifications of the implant unit 200 are not limited to a specific embodiment, as long as the implant unit 200 is configured for use with the method described herein.

[0055] The external device 300 of the system 100 that can be used to perform the method can be configured to be positioned outside the patient, particularly under the chin of the subject and / or the front of the patient's neck. Therefore, the external device 300 can be configured to be fixed to the patient, for example, by adhering to the patient's skin or by a strap or other device configured to hold the external device in place. The external device 300 may preferably include a housing, wherein the housing may be any suitable container configured to hold electrical components. In addition, the housing may be of any suitable size and / or shape, and may be rigid or flexible. Examples of housings for the external device 300 may include one or more of patches, buttons, or other containers having different shapes and sizes and made of any suitable material. The specifications of the external device 300 are not limited to a specific embodiment, as long as the implant unit 200 is configured to be used with the method described herein.

[0056] To determine the movement (i.e., contraction) of one or more muscles associated with the subject's airway in response to the electric field applied by the implant unit 200, the system 100 includes a motion sensing unit 400, which includes at least one inertial measurement unit 401 and / or at least one strain gauge. The inertial measurement unit may include at least one accelerometer and / or at least one gyroscope and / or at least one magnetometer.

[0057] Finally, the system 100 according to Fig. 1 may comprise a control unit 500, for example as part of the external device 300. The control unit 500 may transmit modulation or stimulation input signals (eg stimulation parameters) and power to the implant unit 200.

[0058] According to the method depicted in FIG. 1 , the control unit 500 may also receive data corresponding to the movement of one or more muscles associated with the subject's breathing or airway determined by the motion sensing unit 400 and assign to it a value associated with the degree of airway patency and / or airway obstruction. According to a preferred embodiment of the method, the control unit 500 is also capable of adjusting at least one of the stimulation parameters in response to the value indicating the degree of airway patency and / or airway obstruction. Therefore, the control unit 500 may include one or more processors, which may include any circuit configured to perform a logical operation on at least one input variable. At least one processor of the control unit 500 may, for example, include one or more integrated circuits, microchips, microcontrollers, and microprocessors, which may be all or part of a central processing unit (CPU), a digital signal processor (DSP), a field programmable gate array (FPGA), or any other circuit known to those skilled in the art that may be suitable for executing instructions or performing logical operations. In this way, a method for feedback-based or closed-loop neural stimulation is provided, in which the efficacy of an ongoing stimulation session is determined by measuring the degree of airway patency and then automatically adjusting the stimulation parameters in response to the measured degree of airway patency. The degree of protrusion of the subject's tongue may be determined, for example, by detecting the movement of muscles associated with the tongue or by detecting the movement of the subject's jaw. Automatic adjustment may include the control unit 500 receiving a value indicative of tongue movement from the motion sensing unit 400 and thereupon adjusting at least one stimulation parameter after a set time delay or more or less immediately (ie in real time).

[0059] According to FIG. 1 , the control unit 500 may be a part of the external device 300 , the implant unit 200 , or both the external device 300 and the implant 200 .

[0060] FIG2 shows a schematic diagram of a system 100 for measuring the degree of airway patency and / or airway obstruction (e.g., muscle displacement) of a subject in response to electrical neural stimulation according to a second embodiment. Compared to the system of FIG1 , the system 100 of FIG2 is further specified as both a motion sensing unit 400 and a control unit 500 are shown as part of the external device 300. In this case, the motion sensing unit 400 may preferably include at least one inertial measurement unit, such as an accelerometer.

[0061] FIG3 depicts a flow chart of a third embodiment of a system 100 for measuring the degree of airway patency (e.g., displacement) of a subject in response to electrical neural stimulation. The system 100 of FIG3 is further designated as a motion sensing unit 400 and a control unit 500, both of which are shown as part of the implant unit 200. In this case, the motion sensing unit 400 may preferably include at least one strain unit configured to detect muscle contraction.

[0062] The invention is not limited to one of the embodiments described herein, but can be modified in many other ways.

[0063] All features and all advantages disclosed in the claims, the description and the drawings, including structural details, spatial arrangements and method steps, may be essential to the invention either per se or in any combination with one another.

[0064] Reference numerals list

[0065] 100 systems

[0066] 200 implant units

[0067] 300 external devices

[0068] 400 motion sensing units

[0069] 500 control unit

Claims

1. A method for measuring the degree of muscle contraction of a subject in response to electrical nerve stimulation, the method comprising: generating a modulation signal, the modulation signal comprising an electrical stimulation pattern; applying the modulated signal to at least one pair of electrodes associated with an implant unit implanted in the subject; detecting movement of one or more muscles associated with the airway of the subject in response to the modulated signal applied to the at least one pair of electrodes; The determined motion is assigned a value indicative of the degree of airway patency and / or the degree of airway obstruction.

2. The method according to claim 1, wherein: The method further comprises: At least one parameter of the electrical stimulation pattern is adjusted in response to the value indicative of the degree of airway patency and / or airway obstruction.

3. The method according to claim 1, characterized in that The movement of the muscles associated with the airway of the subject includes airway muscle contraction, a change in the position of the subject's tongue, and / or a change in the spatial orientation of the tongue within the subject.

4. The method according to any one of the preceding claims, characterized in that Movement of the one or more muscles associated with the airway of the subject is determined using at least one motion sensing unit.

5. The method according to claim 4, characterized in that The at least one motion sensing unit comprises at least one inertial measurement unit and / or at least one strain gauge.

6. The method according to claim 5, characterized in that The inertial measurement unit comprises at least one accelerometer and / or at least one gyroscope and / or at least one magnetometer.

7. The method according to any one of claims 2 to 6, characterized in that At least one parameter includes pulse train amplitude, pulse train length, single pulse frequency, single pulse duration, hold duration, pulse train interval, duty cycle, delay time, ramp duration, step-down amplitude, ramp at sequence start duration and / or confirmed pulse / sequence amplitude.

8. A system for implementing the method according to any one of the preceding claims, the system comprising: an implant unit configured for implantation proximate any muscle associated with airway patency and / or airway obstruction of the subject; an external device configured to communicate with the implanted unit; At least one motion sensing unit.

9. The system according to claim 8, wherein: The at least one motion sensing unit is part of the implanted unit and / or wherein the at least one motion sensing unit is part of the external device.

10. Use of the method according to any one of claims 1 to 7 in the treatment of obstructive sleep apnea.